Marta Santisteban

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Immune-Induced Epithelial to Mesenchymal Transition <i>In vivo</i> Generates Breast Cancer Stem Cells

Marta Santisteban, Jennifer M. Reiman, Michael K. Asiedu et al. · Cancer Research · 2009 · 378 citations · Full text

Medicine, Cell Biology, Oncology +17

Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial

Javier Bermejo, Raquel Yotti, Rocío García‐Orta et al. · European Heart Journal · 2017 · 226 citations · Full text

Medicine, Cardiology, Pharmacotherapy +10

Dendritic Cells in Cancer Immunology and Immunotherapy

Laura Hato, Ángel Vizcay Atienza, Iñaki Eguren et al. · Cancers · 2024 · 117 citations · Full text

Life Sciences, Immunology, Oncology +17

Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia

Marta Santisteban, Carol Reynolds, Emily G. Barr Fritcher et al. · Breast Cancer Research and Treatment · 2009 · 71 citations

Medicine, Molecular Biology, Oncology +16